
The Case to Revisit the FDA’s Approval of Abortion Pills
The story of the abortion pill is one of steadily weakening protections for the mother from a drug expressly designed to be lethal to her unborn child. Initial limitations on who may prescribe the drug and what their health care credentials must be have eroded under Democratic administrations to a risky, laissez-faire regimen of no in-person medical supervision, no injury tracking, expanded gestational limits, and attacks on any research, such as that conducted by the Charlotte Lozier Institute (CLI), designed to identify the drug's physical and psychological effects on women who take it or have it foisted upon them.





